Fatigue is a clinically relevant concern for GLP-1 users because it can affect treatment adherence and quality of life
Weight loss and reduced insulation During weight loss, we lose some of our natural insulation
The following mouse strains were used in this study: prp-TDP-43 A315T (procured from Jackson Laboratory, stock no
Kidney Function: Serum creatinine and estimated glomerular filtration rate (eGFR) to evaluate kidney health, as dehydration from GLP-1 side effects can sometimes impact kidney function
Weight loss timelines vary based on genetics, lifestyle, and initial dosesome patients observe results within 2 weeks, while others require 68 weeks to perceive consistent changes
Safety Evidence : Does the paper report adverse events, discontinuation, tolerability, or safety concerns